Cover Image

A clinical systematic literature review of treatments among patients with advanced and/or metastatic human epidermal growth factor receptor 2 positive breast cancer

Aim: This systematic literature review aims to summarize the efficacy/effectiveness of treatments, including eribulin (ERI)-based and anti-human epidermal growth factor receptor 2 (HER2) treatments in advanced/metastatic HER2+ breast cancer. Methods: Three databases from 2016 to September 2021 were...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kerigo Ndirangu (Author), Rachel Goldgrub (Author), Vanita Tongbram (Author), Rajee Anton (Author), Bagrat Lalayan (Author), Joyce O'Shaughnessy (Author), Sarah E Schellhorn (Author)
Format:	Book
Published:	Becaris Publishing Limited, 2024-05-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

A network meta-analysis of immunotherapy-based treatments for advanced nonsquamous non-small cell lung cancer
by: Himani Aggarwal, et al.
Published: (2023)

Cost of disease progression among US patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
by: Clara Lam, et al.
Published: (2024)

Nuclear epidermal growth factor receptor as a therapeutic target
by: Benjamin Atwell, et al.
Published: (2023)

Utilization and costs of epidermal growth factor receptor mutation testing and targeted therapy in Medicare patients with metastatic lung adenocarcinoma
by: Chan Shen, et al.
Published: (2022)

Metastatic Squamous Cell Carcinoma from Lung Adenocarcinoma after Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy
by: Hyung Kyu Park, et al.
Published: (2017)

Epidermal Growth Factor Receptor immunohistochemical expression in hepatocellular carcinoma without Epidermal Growth Factor Receptor exons 18-21 mutations
by: Nikolova Dafina, et al.
Published: (2022)

Pertuzumab in human epidermal growth-factor receptor 2-positive breast cancer: clinical and economic considerations
by: Lamond NW, et al.
Published: (2014)

Epidermal growth factor receptor: Role in human cancer
by: Prashanth Rajaram, et al.
Published: (2017)

Modulation of Pathological Pain by Epidermal Growth Factor Receptor
by: Jazlyn P. Borges, et al.
Published: (2021)

Metastatic dermatosis in breast carcinoma on adjuvant trastuzumab: Is skin a sanctuary site in human epidermal growth factor receptor-2-amplified disease?
by: Amit Sehrawat, et al.
Published: (2018)

Transcriptional effects of inhibiting epidermal growth factor receptor in keratinocytes
by: Alix Gazel, et al.
Published: (2013)

The role of p21/CIP1/WAF1 (p21) in the negative regulation of the growth hormone/growth hormone receptor and epidermal growth factor/epidermal growth factor receptor pathways, in growth hormone transduction defect
by: Eirini Kostopoulou, et al.
Published: (2018)

Nanodelivery Systems Targeting Epidermal Growth Factor Receptors for Glioma Management
by: Sathishbabu Paranthaman, et al.
Published: (2020)

Risk factors associated with trastuzumab-induced cardiotoxicity in patients with human epidermal growth factor receptor 2-positive breast cancer
by: Wesam Abdel-Razaq, et al.
Published: (2019)

Enseñanza de idiomas, educación para el desarrollo y antirracismo: una autorreflexión crítica de un profesor británico
by: Martín O'SHAUGHNESSY
Published: (2009)

A paradigm shift for the treatment of hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) advanced breast cancer: a review of CDK inhibitors
by: Mariane Teodoro Fernandes, et al.
Published: (2018)

Mucin Production Correlates with Dual Expression of Epidermal Growth Factor Receptor and Its Ligand the Epidermal Growth Factor in Non-Small Cell Lung Cancer
by: Rancés Blanco, et al.
Published: (2017)

Six cases of purpuric eruptions induced by epidermal growth factor receptor inhibitors
by: Tomoko Hiraiwa, et al.
Published: (2018)

Idiopathic extensive acanthosis nigricans with a variant of the epidermal growth factor receptor
by: Amena Alkeswani, BS, et al.
Published: (2020)

Dermatological side effects of epidermal growth factor receptor inhibitors: 'Pride' complex
by: Bhushan Madke, et al.
Published: (2014)

The roles of epidermal growth factor receptor (EGFR) inhibitors in the management of lung cancer
by: Ashwaq Al Olayan, et al.
Published: (2012)

Desensitization by Different Strategies of Epidermal Growth Factor Receptor and ErbB4
by: Hideyuki Yamamoto, et al.
Published: (2014)

Immune responses to epidermal growth factor receptor (EGFR) and their application for cancer treatment
by: Tetsuro Sasada, et al.
Published: (2016)

Cardiotoxicity of Epidermal Growth Factor Receptor 2-Targeted Drugs for Breast Cancer
by: ZiYan Yang, et al.
Published: (2021)

Bucillamine Prevents Afatinib-Mediated Inhibition of Epidermal Growth Factor Receptor Signaling
by: Naoyuki Nishiya, et al.
Published: (2019)

Mouse Syngeneic Melanoma Model with Human Epidermal Growth Factor Receptor Expression
by: Tatiana A. Slastnikova, et al.
Published: (2022)

Oestrogen receptor β5 and epidermal growth factor receptor synergistically promote lung cancer progression
by: Yuquan Bai, et al.
Published: (2018)

Successful Treatment of Epidermal Growth Factor Receptor Inhibitor-Induced Periungual Inflammation with Adapalene
by: Junichi Hachisuka, et al.
Published: (2011)

Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
by: K. Chanprapaph, et al.
Published: (2014)

Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab
by: Daanish Hoda, et al.
Published: (2008)

Epidermal Growth Factor Receptor: A Potential Therapeutic Target for Diabetic Kidney Disease
by: Lili Sheng, et al.
Published: (2021)

Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer
by: Xueke Zhou, et al.
Published: (2010)

Angiogenesis and epidermal growth factor receptor inhibitors in non-small cell lung cancer
by: Giuliano Palumbo, et al.
Published: (2020)

Epidermal growth factor receptor mutations in adenocarcinoma lung: Comparison of techniques for mutation detection
by: Saumya Shukla, et al.
Published: (2022)

Role of Epidermal Growth Factor Receptor (EGFR) and Its Ligands in Kidney Inflammation and Damage
by: Sandra Rayego-Mateos, et al.
Published: (2018)

Mutations in epidermal growth factor receptor and K-ras in Chinese patients with colorectal cancer
by: Xueke Zhou, et al.
Published: (2010)

Epidermal growth factor receptor (EGFR) overexpression in endometrial carcinoma: association with histopathologic parameters
by: Atif Ali Hashmi, et al.
Published: (2019)

The Role of Epidermal Growth Factor Receptor Family of Receptor Tyrosine Kinases in Mediating Diabetes-Induced Cardiovascular Complications
by: Bara A. Shraim, et al.
Published: (2021)

Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor (VEGF) expression in Sinonasal Inverted Papillomas
by: Mario Bilic, et al.
Published: (2018)

A validation study of human epidermal growth factor receptor 2 immunohistochemistry digital imaging analysis and its correlation with human epidermal growth factor receptor 2 fluorescence In situ hybridization results in breast carcinoma
by: Ramon Hartage, et al.
Published: (2020)